Last reviewed · How we verify

1 month Rifapentine, Isoniazid and Vitamin B6 — Competitive Intelligence Brief

1 month Rifapentine, Isoniazid and Vitamin B6 (1 month Rifapentine, Isoniazid and Vitamin B6) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

1 month Rifapentine, Isoniazid and Vitamin B6 (1 month Rifapentine, Isoniazid and Vitamin B6) — Rutgers, The State University of New Jersey.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
1 month Rifapentine, Isoniazid and Vitamin B6 TARGET 1 month Rifapentine, Isoniazid and Vitamin B6 Rutgers, The State University of New Jersey marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 1 month Rifapentine, Isoniazid and Vitamin B6 — Competitive Intelligence Brief. https://druglandscape.com/ci/1-month-rifapentine-isoniazid-and-vitamin-b6. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: